
Elvanse for ADHD
Some of the children who have been diagnosed with ADHD also have the symptoms in adulthood. In adults, the symptoms should have started in childhood when treatment is initiated.
Elvanse is a modified form of dexamfetamine that remains inactive until the body breaks it down into its active form. After absorption, it is changed into dexamfetamine, a stimulant that aids in controlling impulse control, focus, and attention.
| Type of Medicine | A stimulant |
|---|---|
| Used for | Attention deficit hyperactivity disorder (ADHD) in children aged over 6 years, young people and adults |
| Also called | Elvanse; Elvanse Adult |
| Available as | Capsules |
Lisdexamfetamine will help to reduce the symptoms of hyperactivity and impulse behaviour and increase attention and concentration span. It is used as part of a comprehensive treatment programme that includes behavioural therapy.
With just one morning dosage, Elvanse can provide long-lasting symptom control throughout the day thanks to this gradual conversion.
What is Lisdexamfetamine available as?
- Capsules: 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg; contain gelatine.
When should Lisdexamfetamine be given?
Lisdexamfetamine is usually taken once each day. It is recommended to give the medicine in the morning, but it may also be taken in the evening.
Try to give the medicine at the same time each day so that it becomes part of your child’s daily routine, which will make it easier to remember.
How much should be given?
The doctor will decide the amount of medicine (the dose) that is right for your child. The correct dose will be shown on the medicine label.
Treatment usually begins with a low dose, which is gradually increased to find the lowest dose that works effectively. Because lisdexamfetamine can affect pulse and blood pressure, these may need to be checked before any dose adjustments are made.
People taking Elvanse for ADHD often report benefits such as improved focus and concentration.
- Improved focus and concentration
- Decreased impulsive behaviour
- Reduced restlessness and hyperactivity
- Better social, professional, and academic performance
- Greater regularity and structure in daily activities
Elvanse ADHD medicine can significantly improve day-to-day functioning when paired with counselling, family support, and educational initiatives.
A trusted ADHD medication, Elvanse is made to offer consistent, efficient support all day long. Your treatment will always be handled professionally and with care when you work with Pharmazon HomeCare.
To ensure your comfort and security, we take the following measures:
✅ Dispensed only with full clinical and legal checks
✅ Ongoing support from experienced pharmacists
✅ Reliable, discreet next-day delivery direct to your door
✅ Trusted by clinics and patients across the UK
With the right guidance and ongoing support, Elvanse can help you manage ADHD symptoms with confidence.
Always consult your doctor before starting Elvanse.
ADHD Medication Prices
Prices start from the amounts shown and vary by strength and pack size. A valid prescription is required for every item.
Elvanse Capsules (Lisdexamfetamine)
From £74.79
Price per pack
See strengths and pack sizesConcerta XL Tablets (Methylphenidate)
From £43.11
Price per pack
See strengths and pack sizesMethylphenidate Tablets (Immediate-release)
From £15.09
Price per pack
See strengths and pack sizesMethylphenidate XL Tablets (Prolonged-release)
From £34.75
Price per pack
See strengths and pack sizes
Frequently Asked Questions About Elvanse for ADHD
Is Elvanse the same as Vyvanse?
Yes. Elvanse and Vyvanse both contain the same active ingredient, lisdexamfetamine dimesylate. Elvanse is the brand name used in the UK and much of Europe, while Vyvanse is the equivalent brand name used in the US and Canada. They are the same medication marketed under different names in different regions.
Is Elvanse currently available, and how quickly can it be delivered?
Elvanse availability can vary from time to time due to national supply factors affecting ADHD medications generally. Once a valid prescription has been received and verified, Pharmazon HomeCare aims to dispense and dispatch it promptly, with delivery timescales depending on your location and prescription type. If a specific strength is temporarily unavailable, our pharmacy team will contact you directly to discuss the best next step.
Is Elvanse a controlled drug in the UK?
Yes. Elvanse is classified as a Schedule 2 Controlled Drug under the Misuse of Drugs Regulations 2001. This means it is subject to strict legal requirements around prescribing, dispensing, and secure storage, and can only be supplied against a valid prescription from a registered UK prescriber.
Can clinics and prescribers send Elvanse prescriptions directly to Pharmazon HomeCare?
Yes. Consultant psychiatrists, GPs, independent prescribers, and private ADHD clinics can send Elvanse prescriptions directly to Pharmazon HomeCare via secure electronic transfer or post. Our pharmacy team verifies each prescription, manages dispensing in line with controlled drug requirements, and coordinates delivery to the patient, keeping the prescribing team informed as needed.
Can Elvanse be delivered to my home?
Once a valid prescription has been received and verified by a GPhC-registered pharmacist, eligible patients can arrange secure, tracked medication delivery through Pharmazon HomeCare.
Reviewed by Archna Gudka, a GPhC-registered pharmacist with over two decades of experience in pharmacy, including 18 years in community pharmacy providing front-line patient care. At Pharmazon HomeCare, an ADHD specialist pharmacy, she has spent the past three years developing her clinical expertise in the management of ADHD and other neurodevelopmental conditions, supported by additional specialist training from the UK Adult ADHD Network (UKAAN). Her areas of clinical focus include ADHD care, neurodevelopmental support, weight management, and evidence-based, patient-centred pharmacy practice. This content is provided for general information only and should not replace personalised advice from your prescribing clinician or pharmacist. Next review: December 2026.